{"entity":{"type":"insider","cik":"0001805097","url":"/insider/0001805097","json_url":"/insider/0001805097.json","name":"Ballal Rahul D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":10,"first":"2020-12-16","last":"2024-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Ballal Rahul D.","source":"filing","n_filings":10,"first_seen":"2020-12-16","last_seen":"2024-11-12"}],"transactions":[{"id":2045705,"accession":"0001439222-24-000142","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001439222-24-000142","line_url":"/filing/0001439222-24-000142#line-7","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4929.0,"shares_display":"4,929","price_per_share":58.57,"price_display":"58.57","price_state":"stated","total_value":288691.53,"total_display":"288,691.53","shares_owned_after":9492.0,"shares_owned_after_display":"9,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2045704,"accession":"0001439222-24-000142","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-24-000142","line_url":"/filing/0001439222-24-000142#line-6","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3571.0,"shares_display":"3,571","price_per_share":57.24,"price_display":"57.24","price_state":"stated","total_value":204404.04,"total_display":"204,404.04","shares_owned_after":14421.0,"shares_owned_after_display":"14,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2045703,"accession":"0001439222-24-000142","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001439222-24-000142","line_url":"/filing/0001439222-24-000142#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":59.21,"price_display":"59.21","price_state":"stated","total_value":88815.0,"total_display":"88,815.00","shares_owned_after":7992.0,"shares_owned_after_display":"7,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2045701,"accession":"0001439222-24-000142","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-24-000142","line_url":"/filing/0001439222-24-000142#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8132.0,"shares_display":"8,132","price_per_share":53.32,"price_display":"53.32","price_state":"stated","total_value":433598.24,"total_display":"433,598.24","shares_owned_after":9860.0,"shares_owned_after_display":"9,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider"},{"id":2045700,"accession":"0001439222-24-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000142","line_url":"/filing/0001439222-24-000142#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1868.0,"shares_display":"1,868","price_per_share":54.41,"price_display":"54.41","price_state":"stated","total_value":101637.88,"total_display":"101,637.88","shares_owned_after":7992.0,"shares_owned_after_display":"7,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider"},{"id":3055078,"accession":"0001415889-24-024990","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-024990","line_url":"/filing/0001415889-24-024990#line-3","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10420.0,"shares_display":"10,420","price_per_share":28.1725,"price_display":"28.17","price_state":"stated","total_value":293557.45,"total_display":"293,557.45","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-10","scope":"insider"},{"id":2069518,"accession":"0001415889-24-010777","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-010777","line_url":"/filing/0001415889-24-010777#line-7","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30300.0,"shares_display":"30,300","price_per_share":23.1361,"price_display":"23.14","price_state":"stated","total_value":701023.83,"total_display":"701,023.83","shares_owned_after":45441.0,"shares_owned_after_display":"45,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-12","scope":"insider"},{"id":2069516,"accession":"0001415889-24-010777","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-010777","line_url":"/filing/0001415889-24-010777#line-6","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20032.0,"shares_display":"20,032","price_per_share":24.9951,"price_display":"25.00","price_state":"stated","total_value":500701.8432,"total_display":"500,701.84","shares_owned_after":25409.0,"shares_owned_after_display":"25,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-12","scope":"insider"},{"id":2069514,"accession":"0001415889-24-010777","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-010777","line_url":"/filing/0001415889-24-010777#line-5","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3068.0,"shares_display":"3,068","price_per_share":25.2094,"price_display":"25.21","price_state":"stated","total_value":77342.4392,"total_display":"77,342.44","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-12","scope":"insider"},{"id":2069510,"accession":"0001415889-24-010777","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010777","line_url":"/filing/0001415889-24-010777#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13600.0,"shares_display":"13,600","price_per_share":21.0106,"price_display":"21.01","price_state":"stated","total_value":285744.16,"total_display":"285,744.16","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-04-12","scope":"insider"},{"id":3053308,"accession":"0001415889-24-010520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010520","line_url":"/filing/0001415889-24-010520#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3485.0,"shares_display":"3,485","price_per_share":19.1476,"price_display":"19.15","price_state":"stated","total_value":66729.386,"total_display":"66,729.39","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":3141313,"accession":"0001415889-24-010232","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-010232","line_url":"/filing/0001415889-24-010232#line-3","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3237.0,"shares_display":"3,237","price_per_share":19.0789,"price_display":"19.08","price_state":"stated","total_value":61758.3993,"total_display":"61,758.40","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2155557,"accession":"0001415889-24-009019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009019","line_url":"/filing/0001415889-24-009019#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13278.0,"shares_display":"13,278","price_per_share":19.1642,"price_display":"19.16","price_state":"stated","total_value":254462.2476,"total_display":"254,462.25","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":8494177,"accession":"0001209191-23-012015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-012015","line_url":"/filing/0001209191-23-012015#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32861.0,"shares_display":"32,861","price_per_share":4.66,"price_display":"4.66","price_state":"stated","total_value":153132.26,"total_display":"153,132.26","shares_owned_after":87835.0,"shares_owned_after_display":"87,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-22","scope":"insider"},{"id":8542929,"accession":"0001209191-23-005993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005993","line_url":"/filing/0001209191-23-005993#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11313.0,"shares_display":"11,313","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":44233.83,"total_display":"44,233.83","shares_owned_after":120696.0,"shares_owned_after_display":"120,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":2885259,"accession":"0001209191-20-064659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-064659","line_url":"/filing/0001209191-20-064659#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4999.0,"shares_display":"4,999","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":124975.0,"total_display":"124,975.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-21","scope":"insider"},{"id":3095943,"accession":"0001209191-20-063780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-063780","line_url":"/filing/0001209191-20-063780#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001805097","owner_name":"Ballal Rahul D.","owner_url":"/insider/0001805097","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":25.0,"total_display":"25.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Director","n_filings":1,"first_seen":"2024-11-12","last_seen":"2024-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Director, Officer (Chief Executive Officer)","n_filings":9,"first_seen":"2020-12-16","last_seen":"2024-10-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001805097","retrieved_at":"2026-08-21T14:50:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}